IMV
IMV is a clinical-stage immuno-oncology company that wants to transform the way they engage human immunity to address some of the most complex, devastating diseases in today’s medical landscape.
IMV
Industry:
Biotechnology Health Care
Founded:
2000-01-01
Address:
Dartmouth, Nova Scotia, Canada
Country:
Canada
Website Url:
http://www.imv-inc.com
Total Employee:
11+
Status:
Active
Contact:
+1 (902) 492-1819
Total Funding:
79.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Arch Oncology
Arch Oncology is an immuno-oncology company
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Beyeonics
A Surgical visualization company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Disc Medicine
Disc Medicine is a hematology company
Endpoint Health
Precision Immunology Therapies
EpicentRx Inc
EpicentRx Inc is a clinical-stage immuno-oncology company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company.
ImmuneID
ImmuneID is a precision immunology company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
Medicenna Therapeutics
Medicenna is a clinical stage, privately held, immuno-oncology company.
NanOlogy
NanOlogy™ is a clinical-stage oncology company
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Paragon Genomics, Inc.
provide high-quality target enrichment solutions to the genomics community to advance precision medicine and research
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
The Honeycomb Clinic
Medical Co-Working Space
uMobile
UMobile is an application developing company.
Current Employees Featured
Founder
Stock Details
Investors List
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Post-IPO Equity - IMV
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - IMV
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Post-IPO Equity - IMV
Official Site Inspections
http://www.imv-inc.com Semrush global rank: 1.19 M Semrush visits lastest month: 25.9 K
- Host name: 104.21.92.162
- IP address: 104.21.92.162
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "IMV"
Corporate Governance :: IMV Inc. (IMV)
IMV Inc. is a clinical-stage immuno-oncology company dedicated to making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer …See details»
Governance Documents :: IMV Inc. (IMV)
IMV Inc. is a clinical-stage immuno-oncology company dedicated to making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer …See details»
IMV Inc - Crunchbase Company Profile & Funding
IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s …See details»
IMV Inc. Financial Overview, Employee Count, and Competitors
IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Company's immune-educating platform: the DPX® technology. Through a differentiated …See details»
IMV (Canada) Company Profile 2024: Valuation, …
IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, Biotechnology. Dartmouth, Canada. 63 As of 2022 000.00. 000000&0 000.00. 000000. orem ipsum dolor sit amet, …See details»
IMV Inc. - AnnualReports.com
IMV Inc. is a clinical-stage immuno-oncology company dedicated to making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer …See details»
IMV Inc. (IMVIF) Company Profile & Overview - Stock Analysis
Aug 15, 2024 IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX, an immune-educating technology platform for …See details»
IMV - Crunchbase Company Profile & Funding
IMV is a clinical-stage immuno-oncology company that wants to transform the way they engage human immunity to address some of the most complex, devastating diseases in today’s medical landscape. Lists Featuring This …See details»
IMV Inc. - LinkedIn
IMV Inc. | 4,330 followers on LinkedIn. Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers | IMV Inc. is a clinical …See details»
Governance - IMV Inc.
Andrew brings more than 20 years of executive experience in biopharmaceuticals and life science. He has spent his career focused on corporate and portfolio strategy, as well as …See details»
About IMV - IMV CORPORATION
IMV EUROPE LIMITED. 1 Dunsbridge Business Park, Shepreth, Royston, Herts, SG8 6RA, UKSee details»
Court grants creditor protection to N.S. company developing …
May 1, 2023 IMV — known as Immunovaccine Technologies — disclosed Monday the Nova Scotia Supreme Court has granted an interim order giving it protection under the Companies' …See details»
IMV Inc. Announces Strategic Reorganization
Sep 15, 2022 IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Company’s immune-educating platform, DPX ®. Through a …See details»
IMV Inc. - Canada.ca
Out of that innovation grew IMV Inc., and a potential cure for many cancers. “We are now one of the most advanced companies in the world working on immunotherapy,” says the Halifax …See details»
IMV - Overview, News & Similar companies | ZoomInfo.com
Mar 29, 2023 IMV Receives NASDAQ Delisting Notice DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (the “Company” or “IMV”) (Nasdaq: IMV; …See details»
IMV Inc. Announces Second Quarter 2021 Financial and …
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- IMV Inc. (the “Company” or “IMV”) (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company …See details»
IMV Inc. Announces Strategic Reorganization - The Globe and Mail
Sep 15, 2022 Search stocks, ETFs and Commodities. Instrument Name Imv Inc Instrument Symbol (IMV-Q). Instrument Exchange NASDAQSee details»
IMV Inc. Announces Strategic Reorganization | Business Wire
Sep 15, 2022 IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Company’s immune-educating platform, DPX ®. Through a …See details»
Contacts :: IMV Inc. (IMV)
10 Rogers Street Suite 120 and 121 Cambridge, MA 02142-1288 T: +1 (617)-294-5868See details»